Key result
The heterogeneity of hypertrophic cardiomyopathy patterns, symptoms, and assessment presents a challenge for cardiologists in managing symptoms and preventing sudden cardiac death.
Hypertrophic cardiomyopathy presents with a heterogeneous clinical spectrum, making diagnosis and management challenging but essential for preventing major cardiovascular complications and sudden cardiac death.
HCM phenotype diversity warrants individualized care; leaves open standardized risk stratification.
The clinical spectrum of hypertrophic cardiomyopathy (HCM) is complex and includes a variety of phenotypes, which leads to different types of manifestations.Although most of the patients are asymptomatic, a significant proportion of them will develop symptoms or risk of arrhythmias and sudden cardiac death (SCD).Therefore, the objectives of HCM diagnosis and management are to relieve the patients' symptoms (chest pain, heart failure, syncope, palpitations, etc.), prevent disease progression and major cardiovascular complications and SCD.The heterogeneity of HCM patterns, their symptoms and assessment is a challenge for the cardiologist.
No takes yet. Share an insight, caveat, or question.
A 2015 study conducted a review in Hypertrophic cardiomyopathy (HCM). The heterogeneity of hypertrophic cardiomyopathy patterns, symptoms, and assessment presents a challenge for cardiologists in managing symptoms and preventing sudden cardiac death.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: